Targeted radionuclide therapy: Theoretical study of the relationship between tumour control probability and tumour radius for a 32P/ 33P radionuclide cocktail

Physics in Medicine and Biology

Volumn 53, Issue 7, 2008, Pages 1961-1974

  Lechner, A ^a,b   Blaickner, M ^a   Gianolini, S ^c   Poljanc, K ^b   Aiginger, H ^b   Georg, D ^d  

^a ARC SEIBERSDORF RESEARCH GMBH   (Austria)

^b VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

^c Tomotherapy Europe GmbH   (Belgium)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSCOPIC EXAMINATION; MONTE CARLO METHODS; PROBABILITY; RADIATION EFFECTS; RADIOISOTOPES; RADIOTHERAPY; TUMORS;

CURABILITY; INTRATUMOURAL DISTRIBUTION; MALIGNANCY; RADIATION TRANSPORT SIMULATION; TARGETED RADIONUCLIDE THERAPY (TRT);

ONCOLOGY;

IODINE 131; PHOSPHORUS 32; PHOSPHORUS 33;

ARTICLE; BETA RADIATION; CALCULATION; CANCER CONTROL; CANCER SIZE; COMPUTER MODEL; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG TARGETING; ELECTRON; MATHEMATICAL ANALYSIS; MONTE CARLO METHOD; PRIORITY JOURNAL; PROBABILITY; SIMULATION;

ALGORITHMS; HUMANS; MODELS, STATISTICAL; MONTE CARLO METHOD; NEOPLASM METASTASIS; NEOPLASMS; PHOSPHORUS RADIOISOTOPES; PROBABILITY; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS;

EID: 42449116224     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/53/7/011     Document Type: Article

References (32)

1. Atthey M, Nahum A E, Flower M A and McCready V R 2000 Effects of cellular repair and proliferation on targeted radionuclide therapy: a modelling study Phys. Med. Biol. 45 N15-20
2. Bao A, Zhao X, Phillips W T, Woolley F R, Otto R A, Goins B and Hevezi J M 2005 Theoretical study of the influence of a heterogeneous activity distribution on intratumoral absorbed dose distribution Med. Phys. 32 200-8
3. Bardies M and Chatal J F 1994 Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres Phys. Med. Biol. 39 961-81
4. Bernhardt P, Ahlman H and Forssell-Aronsson E 2003 Model of metastatic growth valuable for radionuclide therapy Med. Phys. 30 3227-32
5. Briesmeister J F (ed) 2000 MCNP™-A general Monte Carlo N-particle transport code, Version 4C Report LA-13709-M (Los Alamos National Laboratory)
6. Chibani O and Li X A 2002 Monte Carlo dose calculations in homogeneous media and at interfaces: a comparison between GEPTS, EGSnrc, MCNP, and measurements Med. Phys. 29 835-47
7. Dewaraja Y K, Wilderman S J, Ljungberg M, Koral K F, Zasadny K and Kaminiski M S 2005 Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation J. Nucl. Med. 46 840-9
8. Flux G, Bardies M, Monsieurs M, Savolainen S, Strand S E and Lassmann M 2006 The impact of PET and SPECT on dosimetry for targeted radionuclide therapy Z. Med. Phys. 16 47-59
9. Goddu S M, Bishayee A, Bouchet L G, Bolch W E, Rao D V and Howell R W 2000 Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases J. Nucl. Med. 41 941-51
10. Humm J L and Cobb L M 1990 Nonuniformity of tumor dose in radioimmunotherapy J. Nucl. Med. 31 75-83
11. Jeraj R, Keall P J and Ostwald P M 1999 Comparison between MCNP, EGS4 and experiment for clinical electron beams Phys. Med. Biol. 44 705-17
12. Kalogianni E, Flux G D and Malaroda A 2007 The use of BED and EUD concepts in heterogeneous radioactivity distributions on a multicellular scale for targeted radionuclide therapy Cancer Biother. Radiopharm. 22 143-50
13. Lenarczyk M, Goddu S M, Rao D V and Howell R W 2001 Biologic dosimetry of bone marrow: induction of micronuclei in reticulocytes after exposure to 32P and 90Y J. Nucl. Med. 42 162-69
14. Love P A, Lewis D G, Al-Affan I A M and Smith C W 1998 Comparison of EGS4 and MCNP Monte Carlo codes when calculating radiotherapy depth doses Phys. Med. Biol. 43 1351-57
15. Malaroda A, Flux G and Ott R 2005 The application of dose-rate volume histograms and survival fractions to multicellular dosimetry Cancer Biother. Radiopharm. 20 58-65
16. Mausner L F, Kolsky K L, Joshi V and Srivastava S C 1998 Radionuclide development at BNL for nuclear medicine therapy Appl. Radiat. Isot. 49 285-94
17. Mausner L F and Srivastava S C 1993 Selection of radionuclides for radioimmunotherapy Med. Phys. 20 503-9
18. Meredith R 2002 Clinical trial design and scoring of radionuclide therapy endpoints: normal organ toxicity and tumor response Cancer. Biother. Radiopharm. 17 83-99
19. Nahum A E 1996 Microdosimetry and radiocurability: modelling targeted therapy with β-emitters Phys. Med. Biol. 41 1957-72
20. Nahum A E and Tait D M 1992 Maximising local control by customised dose prescription for pelvic tumors Advanced Radiation Therapy Tumour Response Monitoring and Treatment Planning ed A Breit (Heidelberg: Springer) pp 425-31
21. O'Donoghue J A 1999 Implications of nonuniform tumor doses for radioimmunotherapy J. Nucl. Med. 40 1337-41
22. O'Donoghue J A, Bardies M and Wheldon T E 1995 Relationship between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides J. Nucl. Med. 36 1902-9
23. Pattillo R A, Collier B D, Abdel-Dayem H, Ozker K, Wilson C, Ruckert A C F and Hamilton K 1995 Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy J. Nucl. Med. 36 29-36
24. Prestwich W V, Nunes J and Kwok C S 1989 Beta dose point kernels for radionuclides of potential use in radioimmunotherapy J. Nucl. Med. 30 1036-46
25. Reynaert N, Palmans H, Thierens H and Jeraj R 2002 Parameter dependence of the MCNP electron transport in determining dose distributions Med. Phys. 29 2446-54
26. Schaart D R, Jansen J T, Zoetelief J and de Leege P F 2002 A comparison of MCNP4C electron transport with ITS 3.0 and experiment at incident energies between 100 keV and 20 MeV: influence of voxel size, substeps and energy indexing algorithm Phys. Med. Biol. 47 1459-84
27. 186Re as a function of tumor size, uptake, and intracellular distribution Int. J. Radiat. Oncol. Biol. Phys. 36 197-204
28. Van Riper K A (ed) 2004 BodyBuilder User's Guide, Version 1.3.0 Report (White Rock Science)
29. Webb S and Nahum A E 1993 A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density Phys. Med. Biol. 38 653-66
30. Wheldon T E and O'Donoghue J A 1990 The radiobiology of targeted radiotherapy Int. J. Radiat. Biol. 58 1-21
31. Wheldon T E, O'Donoghue J A, Barret A and Michalowski A S 1991 The curability of tumours of differing size by targeted radiotherapy using or Radiother. Oncol. 21 91-9
32. Zweit J 1996 Radionuclides and carrier molecules for therapy Phys. Med. Biol. 41 1905-14